Our findings generally agree with Grobler et al.-review, where they described increased levels of P-selectin, VWF and D-dimer during COVID-19 progression and recommended that patients should be managed at early stage when there are high levels of fibrinogen, VWF and P-selectin but normal or slightly increased levels of D-dimer. This evidence concerns the gene SELP and COVID-19.